is liraglutide and semaglutide the same vs vs GLP-1 File:Semaglutide vs. liraglutide v01 SVK.png

GLP-1 receptor agonists are not prescribed solely for cholesterol management , but certain patient groups may derive particular benefit from their lipid-modifying effects alongside their primary indications

The company is also exploring opportunities beyond GLP-1s, indicating a broader focus on innovative injectable therapies

We can support requests for export-friendly labeling, where permitted, and align secondary packaging to logistics needs

Get Evaluated for a Wegovy Prescription Online Today Ready to take control

Additional indications Knee osteoarthritis, sleep apnea, MASLD, cardiovascular outcomes, and chronic low back pain would follow based on their respective trial timelines This mirrors how Lilly handled tirzepatide: Mounjaro was approved for diabetes first (May 2022), followed by Zepbound for obesity (November 2023)

Food and Drug Administration (FDA) to treat diabetes and obesity, have helped patients lose an average of 15%-20% of their total body weight in clinical trials